Locations in over 50 countries with 29 manufacturing plants and 7 R&D centres
Europe
We manufacture injectable medicines in Europe, supplying products to the US, the MENA, and Europe. We have high-quality manufacturing plants in Germany, Italy and Portugal.
Middle East and North Africa (MENA)
The region’s principal player, we create branded generic medicines and are a leading licensing partner. We’re the fifth largest pharmaceutical manufacturer in MENA.
US
We are a top three player by volume in generic injectable medicines and have a strong presence in the non-injectable generics market.
Latest news
Hikma launches prefilled syringes in the US
17 September 2019
Hikma launches Tetrabenazine Tablets
13 September 2019
Hikma launches Phenylephrine Hydrochloride Injection, USP
9 September 2019